Infl Combination Liquid
NDC 43742-2174

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 43742-2174?
  4. Infl Combination Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

Infl Combination (aconitum napellus, adenoviren nosode, bryonia (alba), eucalyptus globulus, eupatorium perfoliatum, gelsemium sempervirens, influenzinum 2023-2024, ipecacuanha, kreosotum, veratrum viride) is a UNAPPROVED HOMEOPATHIC-approved product labeled by Deseret Biologicals, Inc.. This medication is typically used as a actively acquired immunity [pe]. It is supplied as a liquid for oral administration. This product entry covers the primary NDC 43742-2174 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
43742-2174
Proprietary Name:
Infl Combination
Non-Proprietary Name: [1]
Aconitum Napellus, Adenoviren Nosode, Bryonia (alba), Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Influenzinum 2023-2024, Ipecacuanha, Kreosotum, Veratrum Viride
Substance Name: [2]
Aconitum Napellus Whole; Bryonia Alba Root; Eucalyptus Globulus Leaf; Eupatorium Perfoliatum Flowering Top; Gelsemium Sempervirens Root; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Influenza A Virus A/darwin/6/2021 (h3n2) Whole; Influenza A Virus Whole; Influenza B Virus B/austria/1359417/2021 Bvr-26 Whole; Influenza B Virus B/phuket/3073/2013 Bvr-1b Whole; Ipecac; Veratrum Viride Root; Wood Creosote
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.

Labeler & Regulatory Data

Labeler Name: [5]
Deseret Biologicals, Inc.
Labeler Code:
43742
Product Label ID:
d8d1d7b9-97f0-4b71-a589-af7c890a3160
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.

Marketing Timeline

Start Marketing Date: [9]
05-14-2024
End Marketing Date: [10]
07-15-2029
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 43742-2174?

The NDC code 43742-2174 is assigned by the FDA to the product Infl Combination. It is commonly known by its generic name, aconitum napellus, adenoviren nosode, bryonia (alba), eucalyptus globulus, eupatorium perfoliatum, gelsemium sempervirens, influenzinum 2023-2024, ipecacuanha, kreosotum, veratrum viride. This pharmaceutical product is labeled by Deseret Biologicals, Inc. and is currently categorized as listed product. The medication is a liquid administered via oral route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 43742-2174-1. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • ACONITUM NAPELLUS WHOLE (UNII: U0NQ8555JD)
  • ACONITUM NAPELLUS (UNII: U0NQ8555JD) (Active Moiety)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • BRYONIA ALBA ROOT (UNII: T7J046YI2B)
  • BRYONIA ALBA ROOT (UNII: T7J046YI2B) (Active Moiety)
  • EUCALYPTUS GLOBULUS LEAF (UNII: S546YLW6E6)
  • EUCALYPTUS GLOBULUS LEAF (UNII: S546YLW6E6) (Active Moiety)
  • EUPATORIUM PERFOLIATUM FLOWERING TOP (UNII: 1W0775VX6E)
  • EUPATORIUM PERFOLIATUM FLOWERING TOP (UNII: 1W0775VX6E) (Active Moiety)
  • GELSEMIUM SEMPERVIRENS ROOT (UNII: 639KR60Q1Q)
  • GELSEMIUM SEMPERVIRENS ROOT (UNII: 639KR60Q1Q) (Active Moiety)
  • INFLUENZA A VIRUS WHOLE (UNII: R9HH0NDE2E)
  • INFLUENZA A VIRUS WHOLE (UNII: R9HH0NDE2E) (Active Moiety)
  • INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE (UNII: PMY5J4Z7LS)
  • INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE (UNII: PMY5J4Z7LS) (Active Moiety)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE (UNII: CYK5P89K8X)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE (UNII: CYK5P89K8X) (Active Moiety)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE (UNII: PS2DCE2WVF)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE (UNII: PS2DCE2WVF) (Active Moiety)
  • IPECAC (UNII: 62I3C8233L)
  • IPECAC (UNII: 62I3C8233L) (Active Moiety)
  • WOOD CREOSOTE (UNII: 3JYG22FD73)
  • WOOD CREOSOTE (UNII: 3JYG22FD73) (Active Moiety)
  • VERATRUM VIRIDE ROOT (UNII: 197B3Q7T5Q)
  • VERATRUM VIRIDE ROOT (UNII: 197B3Q7T5Q) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes of this product?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the End Marketing Date? This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".